Yoshio Miki

Molecular Biology · 2000–2017

A researcher in the Science corpus: 4 papers; trusts 4 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom Yoshio Miki trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. J. P. Thiery
  2. J. Medema
  3. Adi F. Gazdar

Papers from Yoshio Miki's perspective

Ordered by how strongly the researchers Yoshio Miki trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Epithelial–mesenchymal transitions in tumour progression (Nature Reviews. Cancer)
  2. Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers (Nature Medicine)
  3. Tumor Metastasis: Molecular Insights and Evolving Paradigms (Cell)
  4. Epithelial-mesenchymal transitions in development and disease. (Cell)
  5. Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. (Cancer Research)
  6. affy - analysis of Affymetrix GeneChip data at the probe level (Bioinform.)
  7. Systematic identification of genomic markers of drug sensitivity in cancer cells (Nature)
  8. Adjusting batch effects in microarray expression data using empirical Bayes methods. (Biostatistics)
  9. Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer. (Journal of Clinical Oncology)
  10. An epithelial-mesenchymal transition (EMT) gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance (Clinical Cancer Research)

Their papers